A Study of Insulin Efsitora Alfa (LY3209590) Compared to Degludec in Adults With Type 2 Diabetes Who Are Starting Basal Insulin for the First Time
Clinical trial NCT05362058 · COMPLETED
Trial details
- NCT number
- NCT05362058
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-03
- Primary completion
- 2024-04-10
- Enrollment
- 928
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.